Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
research paper

Indian Pediatr 2016;53: 125-128

Naso-pharyngeal Carriage of Organisms in Children Aged 3-59 months Diagnosed with Severe Community-acquired Pneumonia


Meenu Singh, Amit Agarwal, Rashmi Ranjan Das, #Nishant Jaiswal and #Pallab Ray

From the Department of Pediatrics, Advanced Pediatric Centre and #Department of Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Correspondence to: Dr Meenu Singh, Professor, Advanced Pediatric Centre, PGIMER, Sector -12, Chandigarh, India.
Email: [email protected]

Received: June 30, 2015;
Initial review: August 20, 2015;
Accepted: November 30, 2015.



Objective:
To study the naso-pharyngeal carriage of organisms in children diagnosed with severe pneumonia.

Methods: Nasopharyngeal aspirate and swabs for microbiological analyses were collected from 377 children aged 3-59 months with severe pneumonia.

Results: 28.6% of the samples were positive for S. pneumoniae, 9.6% were positive for H. influenzae, and 8.5% were positive for both the organisms. Respiratory syncytial virus was detected in 27% of samples. The rate of isolation of S. pneumonia and H. influenzae was significantly more in the age group of 12-59 months.

Conclusions: In children with severe pneumonia, most common organisms isolated/detected from naso-pharyngeal aspirates were S.pneumoniae and Respiratory Syncytial Virus.

Keywords: Etiology, Epidemiology, Respiratory Syncytial Virus, Streptococcus pneumoniae.


Pneumonia is the single largest killer of children less than five years of age worldwide [1]; though, it is difficult to identify the etiological agents [2]. Nasopharyngeal aspirates can be used for identification of both bacterial and viral pathogens.

Nasopharyngeal colonization with S.pneumoniae usually precedes pneumonia. Though previous Indian studies have reported etiological agents causing pneumonia in children, only a single study reported the results based on culture of nasopharyngeal aspirates [3]. The present study reports the microbiological data from Chandigarh, which is part of IndiaCLEN multicenter study (ISPOT study) on oral amoxicillin in severe community acquired pneumonia (CAP) in children (Clinical trial Registry of India;CTRI/2010/000629).

Methods

The present study was conducted over a period of 3 years (April 2008 to March 2011). Children aged 3 to 59 months fulfilling the criteria of WHO-defined severe CAP with the ability to take antibiotics orally, and without any radiological consolidation or effusion were included. Those with underlying chronic conditions, HIV, hospitalized for >48 hrs in the last 2 weeks, severe malnutrition, and antibiotic therapy for ł48hrs prior to admission were excluded.

Nasopharyngeal swabs were collected and standard microbiological techniques were used to isolate S. pneumoniae and H. influenzae. Minimum inhibitory concentration (MIC) of amoxicillin and penicillin were measured by E test according to the manufacturer’s instructions (AB Biodisk, Solna, Sweden). The nasopharyngeal aspirates were obtained soon after nasopharyngeal swabbing and tested for Respiratory Syncytial virus (RSV) antigen using ELISA method (Abbott Testpack for RSV from Abbott Diagnostics, Baar, Switzerland). Blood culture was not collected as stable, ambulatory patients were included.

Nasopharyngeal swabs were cultured on 5% sheep blood agar with gentamicin for S. pneumoniae and modified chocolate agar with bacitracin (300 µg/ml) for H. influenzae. After overnight incubation at 360C, plates were observed for growth of S. pneumoniae and H. influenzae. All isolates were identified by standard microbiological methods [4]. For antimicrobial susceptibility testing, six antibiotic discs were tested – cotrimoxazole (2.5 µg trimethoprim and 23.5 µg sulfamethoxazole disc), ampicillin (10µg disc), erythromycin (15µg disc), tetracycline (30 µg disc), cefotaxime (30 µg disc), and ciprofloxacin (5 µg disc). Susceptibility testing was done on Muller hinton agar with 5% sheep blood for S. pneumoniae; that of H. influenzae was done by using the disk diffusion method on Haemophilus test medium. Strains were labeled as sensitive/resistant/intermediate susceptible based on Clinical and Laboratory Standards Institute (CLSI) guidelines [5]. American type culture collection (ATCC) reference strains of S. pneumoniae (ATCC 49619) and H. influenzae (ATCC 49247) were used as controls.

The collected data were analyzed and tabulated by using the statistical package, STATA software (version 12, college station, Texas, USA). Chi-square test was carried out to test the differences between proportions. P-value <0.05 was considered as significant.

Results

A total of 430 children with severe CAP were screened, and 377 (237 males) were included. The exclusive breast-feeding rate was 66.6% till 6 months of age, and timely complementary feeding was started in 77.4% of children. Immunization status was up-to-date (as per history) in 92.8% children, and 35% children were having mild to moderate malnutrition. Auscultatory wheeze was present in 52% cases, and crackles in 76.6% cases. Infiltrates on chest X-ray was present in 63.9% cases.

Of the 377 nasopharyngeal swab (NPS) and aspirate (NPA) cultures, 27% were negative, 8.5% were positive for both S.pneumoniae and H.influenzae, 28.6% were positive for S. pneumoniae and 9.6% were positive for H influenzae. RSV antigen was detected in 27% cases (Table I). Taking in account mixed infections, S. pneumoniae was present in 56.7% (214/377), H influenzae in 30.2% (114/377), and RSV in 53.3% (201/377).

TABLE I	Frequency of Organisms in Nasopharyngeal secretions in Children with 
Community- acquired Severe Pneumonia 
Organisms Home Hospital
 (n=184) (n=193)
S. pneumoniae 52 (28.2) 56 (29)
H. influenzae 17  (9.2) 19 (9.8)
Both organisms 15 (8.1) 17 (8.8)
RSV 49 (26.6) 53 (27.5)
H. influenzae + RSV 14 (7.6) 11 (5.7)
S. pneumoniae + RSV 25 (13.6) 28 (14.5)
All three organisms 12 (6.5) 9 (4.7)
RSV – Respiratory syncytial virus; values in no. (%).

The rate of isolation of the organisms according to different subgroups is presented in Table II. Regarding S. pneumoniae, the rates of isolation in 3 to <12months vs. 12 to 59 months were significantly different (38% vs. 70%, P=0.026), but the rates did not differ in other subgroups. The rates of isolation of H. influenzae in 3 to <12 months vs. 12 to 59 months (27.8% vs. 72.2%, P=0.039) were significantly different, but the rates did not differ in other subgroups.

TABLE II Organisms from Nasopharyngeal Secretions by Subgroups
Characteristics S. pneumoniae (+) H. influenzae (+) S. pneumoniae & H. influenzae (+) RSV (+)
Male 57 (52.7%) 23 (63.9%) 17 (53.1%) 54 (52.9%)
Female 51 (47.3%) 13 (36.1%) 15 (46.9%) 48 (47.1%)
3 mo – <12 mo 40 (37%) 10 (27.8%) 14 (43.8%) 56 (54.9%)
12 mo – 59 mo 68 (63%) 26 (72.2%) 18 (56.2%) 46 (45.1%)
Auscultatory wheeze 52/196 (26.5%) 17/196 (8.7%) 19/196 (9.7%) 64/196 (32.6%)
No auscultatory wheeze 56/181 (30.9%) 19/181(10.5%) 13/181 (7.2%) 38/181 (21%)
Crackles 85/289 (29.4%) 27/289 (9.3%) 24/289 (8.3%) 71/289 (24.6%)
No crackles 23/88 (26.1%) 09/88 (10.2%) 08/88 (9%) 31/88 (35.2%)
Infiltrates on chest X-ray  76/241 (31.5%) 23/241 (9.5%) 20/241 (8.3%) 68/241 (28.2%)
Normal chest X-ray  32/136 (23.5%) 13/136 (9.6%) 12/136 (8.8%) 34/136 (25%)

Of the 108 S. pneumoniae isolates, 20.4% were susceptible to co-trimoxazole, 31.5% to tetracycline, and 100% to ampicillin, erythromycin, cefotaxime, and ciprofloxacin. Of the 36 H. influenzae isolates, 27.8% were susceptible to co-trimoxazole, 38.9% to tetracycline, and 100% to ampicillin, erythromycin, cefotaxime, and ciprofloxacin.

Discussion

In the present study, the most common organisms isolated/detected from nasopharyngeal swab (NPS) and aspirate (NPA) cultures were S. pneumoniae and RSV. All the isolates of S. pneumoniae and H. influenzae were susceptible to ampicillin, erythromycin, cefotaxime, and ciprofloxacin.

Limitations of present study include: only children presenting to the health facility were recruited, only nasopharyngeal aspirate was used to identify the organisms, a single center data was presented, and some other organisms were not studied for identification. As the carriage of an organism does not necessarily correlate with the etiology of the pneumonia, non-inclusion of simultaneous age-matched controls is also a limitation. The details of vaccines received by children were also not studied.

Present study results are consistent with some previous results from India. The rate of isolation in previous Indian studies for S. pneumoniae was 9% to 40%, for RSV was 13% to 25%, and for H. influenzae was 7.6% to 22.7% [2,3,6-12]. Present study also noted a higher carriage rate of the organisms in the 12-59 months age group compared to the infants (<12 months), and there was no sex predilection. It has been debated that nasopharyngeal colonization may or may not translate into disease itself. Though this is true, studies have shown nasopharyngeal colonization to be a risk factor for development of pneumonia. In a study from China, compared to controls, the isolation of S. pneumoniae was more in children with radiologically-confirmed pneumonias [13].

Previous Indian studies [7,14,15] have shown the susceptibility pattern of both the organisms as follows: S. pneumoniae being sensitive to penicillin/ampicillin (65%-98.7%), co-trimoxazole (9.1%-81.8%), chloramphenicol (83.4%-94.6%), tetracycline (39.2%), erythromycin (87.5%-89.1%), and ceftriaxone (85%-100%). H.influenza being sensitive to penicillin/ampicillin (59%-81.1%), co-trimoxazole (32.7%-48%), chloramphenicol (45%-81.5%), tetracycline (75%), erythromycin (72.4%), and ceftriaxone (100%). Present study found 100% susceptibility rate of both the organisms to ampicillin, erythromycin, cefotaxime, and ciprofloxacin.

Future research should focus on comparing the organisms isolated from healthy children to those having pneumonia. Simultaneous blood culture to know the exact etiology/pathogenecity of the organism isolated, newer methods of isolation of organisms, serotyping of the bacterial isolates, and testing of additional bacterial isolates should be done to facilitate future policy decisions regarding management of pneumonia in under-five children.

Acknowledgements: Dr Archana Patel, Department of Pediatrics, Indira Gandhi Government Medical College, Nagpur, and Dr Sadbhawna Pandit, Department of Pediatrics, Government Multispecialty Hospital, Chandigarh, for providing logistics and technical assistance for conducting the study.

Contributors: AA and RRD: collected data; PR: performed laboratory tests; RRD, MS, AA and NJ: analyzed data and wrote the manuscript. All authors reviewed and decided to submit the manuscript for publication. MS will act as guarantor of the study.

Funding: IndiaCLEN, USAID and MCH-STAR.

Competing interest: None stated.

 


What This Study Adds?

In children aged 3-59 months with severe community-acquired pneumonia, most common organisms isolated from naso-pharyngeal specimens are S. pneumoniae and RSV.

S pneumoniae and H influenzae show 100% susceptibility to ampicillin, erythromycin, cefotaxime, and ciprofloxacin.


References

1. Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, et al. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013;381:1405-16.

2. Kabra SK, Lodha R, Broor S, Chaudhary R, Ghosh M, Maitreyi RS. Etiology of acute lower respiratory tract infection. Indian J Pediatr. 2003;70:33-6.

3. Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD, ISCAP Study Group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: A multicentre randomised controlled trial. BMJ. 2004;328:791.

4. GV D. Susceptibility of Test of Fastidious bacteria. 6th ed. Washington: American Society for American Microbiology; 1995.

5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement: Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2007. CLSI document M100-S17.

6. Jain A, Kumar P, Awasthi S. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in North Indian schoolchildren. Trop Med Int Health. 2005;10:234-9.

7. Patwari AK, Bisht S, Srinivasan A, Deb M, Chattopadhya D. Aetiology of pneumonia in hospitalized children. J Trop Pediatr. 1996;42:15-20.

8. Broor S, Parveen S, Bharaj P, Prasad VS, Srinivasulu KN, Sumanth KM, et al. A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India. PLoS One. 2007;2:e491.

9. Gupta S, Shamsundar R, Shet A, Chawan R, Srinivasa H. Prevalence of respiratory syncytial virus infection among hospitalized children presenting with acute lower respiratory tract infections. Indian J Pediatr. 2011; 78:1495-7.

10. Hemalatha R, Swetha GK, Seshacharyulu M, Radhakrishna KV. Respiratory syncitial virus in children with acute respiratory infections. Indian J Pediatr. 2010;77:755-8.

11. Rajala MS, Sullender WM, Prasad AK, Dar L, Broor S. Genetic variability among Group A and B respiratory syncytial virus isolates from a large referral hospital in New Delhi, India. J Clin Microbiol. 2003;41:2311-6.

12. Singh AK, Jain A, Jain B, Singh KP, Dangi T, Mohan M, et al. Viral aetiology of acute lower respiratory tract illness in hospitalised paediatric patients of a tertiary hospital: one year prospective study. Indian J Med Microbiol. 2014;32:13-8.

13. Levine OS, Liu G, Garman RL, Dowell SF, Yu S, Yang YH. Haemophilus influenzae type b and Streptococcus pneumoniae as causes of pneumonia among children in Beijing, China. Emerg Infect Dis. 2000;6:165-70.

14. Invasive Bacterial Infections Surveillance (IBIS) Group of the International Clinical Epidemiology Network. Are Haemophilus influenzae infections a significant problem in India? A prospective study and review. Clin Infect Dis. 2002;34:949-57.

15. Kumar KLR, Ganaie F, Ashok V. Circulating serotypes and trends in antibiotic resistance of invasive Streptococcus pneumoniae from children under five in Bangalore. J Clin Diagn Res. 2013;7:2716-20.

 

Copyright © 1999-2016 Indian Pediatrics